Boule Diagnostics BOUL.ST · SEK

Its shares trade on Nasdaq Stockholm under the ticker BOUL.ST. It has been listed since 23 June 2011. In the fiscal year to 31 December 2025, it reported revenue of SEK 489.7m and a net loss of SEK 3.8m. At that date it held total assets of SEK 469.6m and shareholders' equity of SEK 167.6m.

Boule Diagnostics AB engages in the development, manufacture, sale and marketing of instruments and consumable products for blood diagnostics. The company is headquartered in Spanga, Stockholm. The company went IPO on 2011-06-23. The firm specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. The company provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Torben JorgensenIndependent Chairman of the BoardSEK 250,000
• Mr. Torben NielsenChief Executive Officer
• Mr. Holger LembrerChief Financial Officer
• Mr. Eduardo PaganiChief Operating Officer
• Ms. Simonetta TumbioloSenior Vice President of Marketing
• Ms. Aishat BislievaSenior Vice President - People & Culture
• Mr. Kiarash FarrSenior Vice President - Commercial Operations
• Mr. David MetrenaSenior Vice President - Commercial Operations
• Mr. Joergen JehanderHead - Development Department
• Mr. Thomas EklundDirectorSEK 300,000
• Mr. Emil HjalmarssonDirectorSEK 125,000
• Ms. Rikke RytterDirector

Overall

49

Environment

20

Social

93

Governance

33

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.